跳至主要内容
临床试验/IRCT2016101830372N1
IRCT2016101830372N1招募中3 期

Comparing the effects of Terminalia Chebula Retz capsule (A product derived from Iranian traditional medicine) with placebo on the level of bleeding, pain and shirinking of the hemorrhoid pile mass: a randomized double-blind placebo-controlled trial

Vice chancellor for research, Shahid Beheshti University of Medical Sciences0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
78 years 至 31 years(—)
性别
All

入选标准

  • Inclusion criteria include 18 to 65 year-old women and men who have grade I and II hemorrhoids. Exclusion criteria include every severe disease; presence of cancer in every part of the body; every disease in anorectal except hemorrhoids; pregnant and lactating women; patients with history of using anticoagulant, antiplatelet drugs, steroids drugs, drugs with flavonoids (less than a month ago) and pain killers (less than a week ago).

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research, Shahid Beheshti University of Medical Sciences

相似试验